External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches

Dr. @WFPeacock published the supporting data gathered when putting together the Mercury trial (the RCT of discharging ED patients with pulmonary embolus). The HESTIA score predicted those with 0% in-hospital and 30-day mortality. https://t.co/77rzg38bU